Literature DB >> 26640143

The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation.

K Goto1,2, S Ishikawa3, R Honma3, K Tanimoto4, N Sakamoto1, K Sentani1, N Oue1, J Teishima2, A Matsubara2, W Yasui1.   

Abstract

The transcribed-ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs, which are absolutely conserved (100%) between the orthologous regions of the human, rat and mouse genomes. Previous studies have described that several T-UCRs show differential expressions in cancers and might be involved in cancer development. We investigated the transcriptional levels of representative 26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa) and gastric cancer (GC). A quantitative reverse transcription-polymerase chain reaction analysis revealed the downregulation of Uc.158+A expression by a DNA methylation-associated mechanism, which was restored by 5-Aza-dC (5-aza-2'-deoxycytidine) treatment. Bisulfite genomic sequencing using cell lines and tissue samples demonstrated cancer-specific CpG hypermethylation in both GC and PCa. However, Uc.416+A was only overexpressed in GC and we identified an miR-153 binding site in the possible regulatory region of Uc.416+A using online databases. Along with a forced expression or knockdown of miR-153 in MKN-74 GC cells, the transcriptional levels of Uc.416+A were significantly disturbed. A luciferase reporter gene assay supported the direct regulation of Uc.416+A expression by miR-153. Furthermore, Uc.416+A was associated with cell growth through the regulation of IGFBP6 (insulin-like growth factor-binding protein 6) in GC. These findings suggest an oncogenic role of Uc.416+A in GC, which suggests that our approach would provide new insights into functional studies of T-UCRs in cancer biology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26640143     DOI: 10.1038/onc.2015.445

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  Characteristic miR-24 Expression in Gastric Cancers among Atomic Bomb Survivors.

Authors:  Yutaka Naito; Naohide Oue; Trang T B Pham; Manabu Yamamoto; Megumu Fujihara; Teruyoshi Ishida; Shoichiro Mukai; Kazuhiro Sentani; Naoya Sakamoto; Eisuke Hida; Hiroki Sasaki; Wataru Yasui
Journal:  Pathobiology       Date:  2015-05-30       Impact factor: 4.342

2.  Analysis of HOX gene expression patterns in human breast cancer.

Authors:  Ho Hur; Ji-Yeon Lee; Hyo Jung Yun; Byeong Woo Park; Myoung Hee Kim
Journal:  Mol Biotechnol       Date:  2014-01       Impact factor: 2.695

3.  Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.

Authors:  Ziqing Wu; Benfu He; Jincan He; Xiangming Mao
Journal:  Prostate       Date:  2012-10-11       Impact factor: 4.104

4.  Expression of Hoxb-5 during human lung development and in congenital lung malformations.

Authors:  MaryAnn V Volpe; Lucia Pham; Marc Lessin; Steven J Ralston; Ina Bhan; Ernest Cutz; Heber C Nielsen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2003-08

Review 5.  Insulin-like growth factor-binding protein-6 and cancer.

Authors:  Leon A Bach; Ping Fu; Zhiyong Yang
Journal:  Clin Sci (Lond)       Date:  2013-02       Impact factor: 6.124

6.  Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.

Authors:  Qin Xu; Qiang Sun; Jianjun Zhang; Jingshuang Yu; Wantao Chen; Zhiyuan Zhang
Journal:  Carcinogenesis       Date:  2012-11-27       Impact factor: 4.944

7.  Expression of miR-486 is a potential prognostic factor after nephrectomy in advanced renal cell carcinoma.

Authors:  Keisuke Goto; Naohide Oue; Shunsuke Shinmei; Kazuhiro Sentani; Naoya Sakamoto; Yutaka Naito; Tetsutaro Hayashi; Jun Teishima; Akio Matsubara; Wataru Yasui
Journal:  Mol Clin Oncol       Date:  2012-11-27

8.  A microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer.

Authors:  Junhua Luo; Qingqing Cai; Wei Wang; Hui Huang; Hong Zeng; Wang He; Weixi Deng; Hao Yu; Eddie Chan; Chi-fai Ng; Jian Huang; Tianxin Lin
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

9.  Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region.

Authors:  Julia Liz; Anna Portela; Marta Soler; Antonio Gómez; Hui Ling; Gracjan Michlewski; George A Calin; Sònia Guil; Manel Esteller
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

10.  MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer.

Authors:  Yutaka Naito; Naoya Sakamoto; Naohide Oue; Masakazu Yashiro; Kazuhiro Sentani; Kazuyoshi Yanagihara; Kosei Hirakawa; Wataru Yasui
Journal:  Cancer Sci       Date:  2014-01-08       Impact factor: 6.716

View more
  13 in total

1.  Transcribed ultraconserved noncoding RNA uc.160 acts as a negative regulator in gastric cancer.

Authors:  Lei Pang; Qiang Li; Yanqing Zhang; Bin Deng; Fan Wu; Jijun Wang; Keyan Wu; Yanbing Ding; Duonan Yu
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

2.  Expression and function of Uc.160+, a transcribed ultraconserved region, in gastric cancer.

Authors:  Ririno Honma; Keisuke Goto; Naoya Sakamoto; Yohei Sekino; Kazuhiro Sentani; Naohide Oue; Wataru Yasui
Journal:  Gastric Cancer       Date:  2017-04-05       Impact factor: 7.370

Review 3.  Role of transcribed ultraconserved regions in gastric cancer and therapeutic perspectives.

Authors:  Shen-Shuo Gao; Zhi-Kai Zhang; Xu-Bin Wang; Yan Ma; Guo-Qing Yin; Xiao-Bo Guo
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

Review 4.  Noncoding RNA actions through IGFs and IGF binding proteins in cancer.

Authors:  Aidan Kerr; Robert C Baxter
Journal:  Oncogene       Date:  2022-05-21       Impact factor: 8.756

5.  Re-expression of microRNA-4319 inhibits growth of prostate cancer via Her-2 suppression.

Authors:  X Lin; Y Wang
Journal:  Clin Transl Oncol       Date:  2018-04-09       Impact factor: 3.405

6.  Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer.

Authors:  Yao-Fei Pei; Ya-Jing Zhang; Yao Lei; Wei-ding Wu; Tong-Hui Ma; Xi-Qiang Liu
Journal:  Oncotarget       Date:  2017-04-04

Review 7.  Non-coding RNAs are promising targets for stem cell-based cancer therapy.

Authors:  Naoya Sakamoto; Ririno Honma; Yohei Sekino; Keisuke Goto; Kazuhiro Sentani; Akira Ishikawa; Naohide Oue; Wataru Yasui
Journal:  Noncoding RNA Res       Date:  2017-05-22

8.  uc.77- Downregulation Promotes Colorectal Cancer Cell Proliferation by Inhibiting FBXW8-Mediated CDK4 Protein Degradation.

Authors:  Zhijian Zheng; Dan Hong; Xiaodong Zhang; Yixin Chang; Ning Sun; Zhenni Lin; Hongyan Li; Shirui Huang; Ruirui Zhang; Qipeng Xie; Haishan Huang; Honglei Jin
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

9.  Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancer.

Authors:  Yohei Sekino; Naoya Sakamoto; Keisuke Goto; Ririno Honma; Yoshinori Shigematsu; Kazuhiro Sentani; Naohide Oue; Jun Teishima; Akio Matsubara; Wataru Yasui
Journal:  Oncotarget       Date:  2017-10-09

10.  Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma.

Authors:  Yohei Sekino; Naoya Sakamoto; Keisuke Goto; Ririno Honma; Yoshinori Shigematsu; Thang Pham Quoc; Kazuhiro Sentani; Naohide Oue; Jun Teishima; Fumi Kawakami; Jose A Karam; Kanishka Sircar; Akio Matsubara; Wataru Yasui
Journal:  BMC Cancer       Date:  2018-10-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.